Lack of prognostic value of pre-treatment neutrophil-to-lymphocyte ratio in early breast cancer

Conclusion: We consider it is important to determine the efficacy of prognostic markers that are easily accessible and of simple, systematic application. However, NLR does not appear to be an independent prognostic factor for recurrence in our population. In this sense, we consider it is important to publish negative results in order to avoid publication bias.
Source: Breast Care - Category: Cancer & Oncology Source Type: research